Danahy Kevin Patrick bought PLSE
September 19, 2025 · Form 4 insider transaction
Danahy Kevin Patrick bought 400 shares of Pulse Biosciences, Inc. at $1.53 per share, a transaction worth $612.00. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
400
Price
$1.53
Total value
$612.00
InsiderDanahy Kevin Patrick
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 19, 2025
Filing dateSeptember 22, 2025
Shares owned after43,698
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025.